GRAIL, LLC

Yahoo Finance • 30 days ago

Here's Why Grail Soared, Again, in November

Key Points Early cancer detection is highly beneficial to sufferers, and Grail's Galleri test offers a solution. The company is the leader in the race for FDA approval, but it could benefit from being part of a larger company. Commercial... Full story

Yahoo Finance • 2 months ago

After-Hours Earnings Report for November 12, 2025 : CSCO, MFC, FLUT, PAAS, ASND, TTEK, CLBT, CELC, GRAL, DLO, LB, WBTN

The following companies are expected to report earnings after hours on 11/12/2025. Visit our Earnings Calendar for a full list of expected earnings releases. Cisco Systems, Inc. (CSCO)is reporting for the quarter ending October 31, 202... Full story

Yahoo Finance • 2 months ago

Here Are Wednesday’s Top Wall Street Analyst Research Calls: AT&T, Beyond Meat, Carvana, Fortinet, Snowflake, Waste Managment and More

Chaay_Tee / iStock via Getty Images 24/7 Wall St. Key Points: The NASDAQ had a rough Tuesday as the Dow Jones Industrials hit an all-time high, and the S&P 500 was up as well. Continued AI bubble concerns and a rotation out of technology... Full story

Yahoo Finance • 2 months ago

GRAIL (GRAL) Is Up 21.5% After Samsung Partnership to Expand Galleri Test in Asia – What's Changed

Samsung C&T and Samsung Electronics announced a US$110 million equity investment in GRAIL and a collaboration to commercialize the Galleri multi-cancer detection test in key Asian markets, with initial distribution exclusively in South Kor... Full story

Yahoo Finance • 3 months ago

Praxis Precision Medicines announces proposed public offering

* Praxis Precision Medicines (NASDAQ:PRAX [https://seekingalpha.com/symbol/PRAX]) said on Thursday it plans to offer shares of its common stock and prefunded warrants in a public offering, with all securities to be sold by the company.... Full story

Yahoo Finance • 3 months ago

Sector Update: Health Care Stocks Softer Late Afternoon

Health care stocks fell late Thursday afternoon with the NYSE Health Care Index down 0.2% and the He PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 3 months ago

Sector Update: Health Care Stocks Advance Thursday Afternoon

Health care stocks rose Thursday afternoon, with the NYSE Health Care Index adding 0.3% and the Heal PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 3 months ago

GRAIL soars on $110M Samsung investment, strategic pact

Samsung Electronics (OTCPK:SSNLF [https://seekingalpha.com/symbol/SSNLF]), Samsung C&T and GRAIL (NASDAQ:GRAL [https://seekingalpha.com/symbol/GRAL]) have signed a binding letter of intent [https://seekingalpha.com/pr/20268703-samsung-and-... Full story

Yahoo Finance • 3 months ago

Samsung and GRAIL Announce Strategic Collaboration to Bring GRAIL's Galleri® Multi-Cancer Early Detection Test to Asia

Samsung C&T and Samsung Electronics Will Make an Equity Investment of $110 Million Into GRAIL, Subject to Closing Conditions Samsung C&T Will Drive Commercialization of Galleri in South Korea With Possible Expansion to Japan and Singapore... Full story

Yahoo Finance • 3 months ago

Noteworthy Friday Option Activity: GSAT, ELV, GRAL

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Globalstar Inc (Symbol: GSAT), where a total of 8,179 contracts have traded so far, representing approximately 817,900 underlying... Full story

Yahoo Finance • 3 months ago

GRAIL Gains Momentum Post-IPO Amid Strong Sales, Partnerships, and Executive Share Activity

GRAIL, Inc. (NASDAQ:GRAL) is one of the 11 Best Performing IPOs in the Last 2 Years. Major sales by top executives at the company follow a strong positive second quarter.GRAIL Gains Momentum Post-IPO Amid Strong Sales, Partnerships, and E... Full story

Yahoo Finance • 4 months ago

GRAIL shares validate InvestingPro's overvalued call with 41% decline

In February 2025, InvestingPro’s Fair Value model identified (NASDAQ:GRAL) as significantly overvalued at $55.02. Six months later, this analysis has proven remarkably accurate, with the stock declining 41% to $34.24, demonstrating the pow... Full story

Yahoo Finance • 5 months ago

Grail updates 2025 cash burn guidance to $310M amid rising Galleri test adoption and expanded partnerships

Earnings Call Insights: GRAIL, Inc. (GRAL) Q2 2025 MANAGEMENT VIEW * CEO Robert P. Ragusa reported continued strong commercial momentum, highlighting that "Galleri test orders continue to grow at a strong clip with more than 45,000 Gal... Full story

Yahoo Finance • 5 months ago

GRAIL INC (NASDAQ:GRAL) Reports Mixed Q2 2025 Earnings: Revenue Misses, Loss Narrows

GRAIL INC (NASDAQ:GRAL [https://www.chartmill.com/stock/quote/GRAL/profile]) reported its second-quarter 2025 financial results, revealing mixed performance relative to analyst expectations. The company, which focuses on early cancer detec... Full story

Yahoo Finance • 6 months ago

Grail (GRAL) PT Hiked to $38 at Morgan Stanley amid ‘Equal Weight’ Stance

Grail, Inc. (NASDAQ:GRAL) is one of the 15 successful spin-off companies. On June 25, Morgan Stanley reiterated an ‘Equal Weight’ on the stock. However, the investment bank raised its price target to $38 from $20. The adjustment is in resp... Full story

Yahoo Finance • 9 months ago

Jim Cramer Likes GRAIL, Inc. (GRAL) Despite Losses – Great Science, Risky Bet!

We recently published a list of Jim Cramer Put These 16 Stocks Under a Microscope. In this article, we are going to take a look at where GRAIL, Inc. (NASDAQ:GRAL) stands against other stocks that Jim Cramer put under a microscope. On Thur... Full story

Yahoo Finance • 11 months ago

GRAIL and Quest Diagnostics Provide GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System

GRAIL's Galleri Test Now Directly Available to Physicians in the U.S. Through Collaboration With Quest Diagnostics, Delivering a More Streamlined Provider and Patient Experience MENLO PARK, Calif. and SECAUCUS, N.J., Feb. 12, 2025 /PRNews... Full story